Government of India is considering lifting the export ban of Hydroxychloroquine, which has been used as the treatment element for COVID-19. Donald Trump, president of the United States of America has appeared in a public appeal to the Prime Minister Narendra Modi to allow its export in India.
Sources are saying that this export ban might be taken up and would allow them regarding the requirement of the case. They will put on a classified list for those companies, who are going to apply and get a no-objection certificate.
There is an assembly organized by the cabinet secretary and attended by the health secretary and officials of the pharmaceuticals department talked about this issue in detail. Officials stated that there is adequate stock of this medical element.
Hydroxychloroquine, an antiviral medicine additionally utilized by patients of lupus and rheumatoid joint pain, has risen as a questionable treatment for COVID-19. In India, the Indian Council of Medical Research at first prescribed the medication for high-chance human services labourers yet extended the extension a week ago to incorporate patients with extreme respiratory sickness and those in the ICU.
The COVID-19 National Containment Plan has likewise prescribed hydroxychloroquine as a preventive measure for each one of those people moving out of the isolated control zones for fundamental administrations and family unit individuals from COVID-19 tainted patients.